Volatility means opportunity! Watch price changes reflect directly onto your portfolio
Get the facts about trading Regeneron Pharmaceuticals before you start. Discuss investment strategies, review market research, and get real-time updates
685,750 Regeneron Pharmaceuticals positions opened on eToro
Regeneron Pharmaceuticals Inc. was founded in 1988 and is headquartered in Tarrytown, New York. It is a biopharmaceutical company focused on developing and commercializing medical solutions for eye diseases, high levels of cholesterol, asthma, atopic dermatitis, cancer, and other conditions. As of December 31, 2016, the Company has had six FDA-approved medicines, 16 product candidates in clinical development and 15 fully human monoclonal antibody product candidates. The company has collaboration and license agreements with Sanofi, Bayer, Teva and other companies. Learn more about this instrument and start trading.
Use eToro's advanced risk management tools to protect your positions. Enjoy hassle-free deposits and withdrawals, instant execution of trades and a free $100,000 demo account to practice your strategy.